With more than 6 million people living with Alzheimer’s disease it definitely is great news that there are some new medications on the market that are showing the possibility of slowing down the progression of the disease. These medications including Lequmbi and Donanemab are showing specific gains in clients with early-stage memory and cognitive impairment, which is why comprehensive neurological assessments like the assessments we perform are so important. If you or someone you love is noticing a change in mental status an assessment can help you to have a baseline indicating how you are performing presently, so that you can compare the results down the line after you have started treatment. Please take a look at the articles attached to this email that describe the new studies as well as early symptoms of cognitive impairment that shouldn’t go unnoticed. Let us know how we can help!!
